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from the other service however, the patient had not been
seen for three years, and his most recent exams (12/29/2005)ntroduction
enal manifestations in sickle cell disease (SCD) occur in one-
hird of adolescents and young adults.1 These manifestations
ccur because the kidney is sensitive to hypoxia-induced vaso-
cclusion resulting from the adhesion of sickled red blood cells
o the endothelium.2,3 The renal medulla is characterized by
cidosis, hypertension, and hypoxia. These factors promote
he polymerization and sickling of hemoglobin (Hb) S, which
akes this area of the kidney susceptible to changes in the
upply of oxygen.3
Proteinuria associated with anemia increases the risk of
enal insufﬁciency mainly among the elderly with SCD.4 These
hronic complications and the imminent risk of a severe acute
aso-occlusive event should be emphasized to clinicians and
ediatricians who treat SCD patients in emergency rooms,
hich justiﬁes the need to review the clinical ﬁndings of renal
nvolvement enabling diagnosis, monitoring, and early treat-
ent.
This article reports a clinical case of a patient with SCDith a possible diagnosis of renal papillary necrosis and renal
nsufﬁciency that required dialysis.
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We  report on a case of a 30-year-old married mulatto male,
who was born and raised in Sao Paulo and is self-employed.
He presented to the emergency room with dyspnea and
reddish-colored urine that had contained clots for three days
prior to his clinic visit. He had a cough with yellow sputum,
and occasional episodes of bilateral chest pain. For ﬁve days,
he had also experienced diffuse body pain, similar to pre-
vious painful crises, but which evolved to continuous right
ﬂank pain associated with three episodes of gross hematuria.
He reported taking 2 mg/night of clonazepam, dipyrone, and
5 mg/day of folic acid at home. No fever, headache, dysuria, or
edema of the lower limbs was present.
The patient had previously been diagnosed with SCD and
referred to the Hematology Clinic of the Hospital das Clini-
cas of the Medical School, Universidade de São Paulo (FMUSP)
for monitoring. The patient brought with him his recordsna da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.
J. Pereira).
showed preserved renal function (urea: 17 mg/dL and creati-
nine: 0.65 mg/dL). The patient reported having undergone a
 e Terapia Celular. Published by Elsevier Editora Ltda. This is an
mons.org/licenses/by-nc-nd/4.0/).
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Table 1 – Routine laboratory tests.
Parameter Results
Urea (mg/dL) 141
Creatinine (mg/dL) 4.66
Sodium (mEq/L) 130
Potassium (mEq/L) 3.7
Hemoglobin (g/dL) 7.2
Hematocrit (%) 20.4
Leukocytes (×109/L) 27.26
Band cells (×109/L) 0.6
Neutrophils (×109/L) 19.0
Eosinophils (×109/L) 0.3
Lymphocytes (×109/L) 4.9
Monocytes (×109/L) 1.6
Platelets (×109/L) 337.0
C-reactive protein (mg/dL) 145
Ionized calcium (mmol/L) 4.6
Phosphorus (mg/dL) 5.7
Direct bilirubin (mg/dL) 0.8
Indirect bilirubin (mg/dL) 0.95
Urinalysis
pH 6.0
Density 1010
Protein (g/L) 1.0
Urobilinogen (mg/dL) 0.2
Leukocytes (cells/ﬁeld) 100
Red blood cells (cells/ﬁeld) 100
Alkaline phosphatase (U/L) 236
Gamma-GT (U/L) 349
Aspartate aminotransferase (U/L) 45
Alanine aminotransferase (U/L) 25
Lactate dehydrogenase (U/L) 1344
high consumption of oxygen during cellular metabolism, theNo dysmorphic red blood cells were found.
splenectomy ﬁve years previous to admission; this informa-
tion could not be conﬁrmed because it is assumed that at
an adult age, the occurrence of signiﬁcant hyposplenism may
have occurred.
The patient smoked, consumed alcohol (2–3 beers/day),
and was a daily drug user (marijuana plus inhaled and intra-
venous cocaine), but reported being abstinent for three days.
In the physical examination the patient presented with
general overall discoloration of the skin (2+/4+) and icterus
(2+/4+); he was also acyanotic and eupneic. He was afebrile
with a blood pressure of 200/110 mmHg  and a heart rate of
96 beats per minute. On lung auscultation, vesicular breath
sounds were found throughout the chest, as were crepitant
rales in the left pulmonary base; the respiratory rate was
18 breaths per minute. Upon auscultation of the cardiocircu-
latory system, normophonetic rhythmic sounds were found
with two normal sounds and a 1+/6+ systolic panfocal mur-
mur. The abdomen was ﬂat with a splenectomy scar, and pain
was induced upon right ﬂank palpation; the abdomen was also
ﬂaccid, negative on abdominal decompression test, and neg-
ative for Giordano’s sign. An examination of the lower limbs
showed good peripheral perfusion and no edema or signs of
deep venous thrombosis.
Upon arrival at the emergency room (6/18/2010), a chest
X-ray and routine laboratory tests were performed (Table 1).
Hypertensive emergency and uremic syndrome were
identiﬁed in association with severe low back pain and 2 0 1 6;3  8(3):267–270
a possible concomitant infection. The indication of treat-
ment included emergency treatment for hypertension with
sodium nitroprusside, antibiotics (ceftriaxone 1 g IV b.i.d.
and clarithromycin 250 mg IV b.i.d.) for possible urinary and
tracheal-bronchial infections, and emergency hemodialysis.
A Doppler ultrasound (US) of the renal arteries revealed
right renal hydronephrosis with the right kidney measuring
12 cm,  a hyperechoic right kidney without obstruction and
no thrombi in the renal arteries and veins. Moreover, US
showed a hyperechoic left kidney measuring 10 cm,  without
hydronephrosis. An abdomen and pelvic computed tomogra-
phy (CT) revealed mild/moderate right pyelocalyceal dilatation
and proximal ureteral ectasia with hyperattenuating material
in the middle third (clot). Hydronephrosis was not identiﬁed
in the left kidney. A presumptive diagnosis was made of renal
infarction and renal papillary necrosis complicated by SCD.
After the patient’s blood pressure was stabilized and antibi-
otic treatment was completed, he continued to receive chronic
dialysis as an outpatient.
Discussion
Fortunately, renal changes that occur in patients with SCD
are less severe, usually have a slower onset, and are less pro-
gressive than the renal changes that this patient experienced.
Three years previously, the patient had preserved renal func-
tion, and therefore, it is suggested that an acute condition
occurred at the time of admission, remembering that the time
from loss of renal function to dialysis levels is very short in
chronic infarctions. In addition, the kidney imaging at admis-
sion indicated no contracted kidney (secondary to ﬁbrosis), as
occurs in chronic infarctions. In this case, the clinical picture
was one of a sudden onset of renal papillary necrosis, which
led to severe renal failure that required dialysis.
The presence of a normal contralateral kidney associ-
ated with an obstructed kidney after papillary necrosis is an
uncommon ﬁnding in cases of severe renal insufﬁciency that
requires dialysis. Possible papillary necrosis of the left kid-
ney was not evident on imaging. In addition, the presence
of a contracted kidney, as occurs in chronic renal infarctions,
was not observed. Notably, these renal changes are the result
of the sickling of red blood cells and vaso-occlusive events.
The adherence of erythrocytes to the vascular endothelium is
likely the primary mechanism by which molecular alterations
that occur in red blood cells affect tissues.5,6
The urinary and pulmonary tract infections also con-
tributed to the patient’s admission to hospital. Among the
conditions that are commonly seen in these patients are
cardiopulmonary complications (especially congestive heart
failure and acute chest syndrome), renal insufﬁciency, and
strokes; infections may precede or be concomitant with these
complications, as was observed in this patient.5,6
In patients with SCD, certain functional and structural
changes in the kidney can be observed. These affect the entire
nephron, from the glomerulus to the renal papilla. Due  to akidney is highly affected in the setting of vaso-occlusive crises,
which are characteristic of SCD. The environment surrounding
the renal medulla is characterized by acidosis, hypertonicity,
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nd hypoxia, and these factors contribute to the sickle cell cri-
is that is responsible for the occlusion of the renal vessels.3
he most important consequence of these crises is damage
o the renal tubules; this causes atrophy or dilation of the
ubules, the presence of protein cylinders, and iron deposition
long with degeneration of the tubule epithelium.1,7
Regarding the patient’s complaint of hematuria, we  note
hat this is a common clinical manifestation. Bleeding occurs
ue to the polymerization of red blood cells within the renal
edulla. In 80% of cases, bleeding occurs in just one kid-
ey. Treatment for hematuria is conservative and includes
ed rest, maintenance of a high urine ﬂow rate, urine alkalin-
zation, and (if necessary) blood transfusions.1 Most episodes
re limited but can occur due to micro infarctions in the
enal pyramids, which may be associated with renal papillary
ecrosis.3,7
Upon admission to the emergency room, the following
linical picture was observed: a hypertensive emergency asso-
iated with renal failure, which previously did not exist. Renal
nsufﬁciency due to nephropathy is observed in 4–21% of adult
CD patients. Renal insufﬁciency is one of the most serious
omplications of this disease and contributes to the early mor-
ality of patients. Disease duration, severity of anemia, and
enetic features are risk factors that inﬂuence the develop-
ent of renal insufﬁciency.8
This patient experienced a long interval during which
is disease was not regularly monitored, and because it
s viewed as a chronic disease, the patient’s serious drug
ddiction problems were detrimental to the clinical and
aboratory parameters of renal impairment prior to hospital-
zation. Several markers have been studied as early indicators
f renal impairment, including the estimated glomerular
ltration rate (eGFR), microalbuminuria, and proteinuria.
icroalbuminuria, an early marker of kidney damage, may be
irectly related to age, and is inversely related to hemoglobin
evels.8
Nephrotic syndrome would indicate a chronic evolution
f focal segmental glomerulosclerosis. However, no clinical
eport revealed nephrotic syndrome prior to the admission of
his patient to the hospital. In addition, clinical symptoms of
cute vaso-occlusive events, such as those that occur in papil-
ary necrosis, were observed. Therefore, imaging exams were
mportant to conﬁrm this ﬁnding.
Renal papillary necrosis is characterized by pyelocalyceal
nd ureteral occlusions, which are due to clots and necrotic
apillae, and may have various causes including diabetes,
nalgesics, and SCD. The main cause of papillary necrosis in
CD is related to the environment of the renal medulla, which
s hypertonic, hypoxic, and favors the sickling of red blood
ells.5 If the ischemic process is due to a temporary spasm
nd normal circulation is restored, the tissues that are affected
ould be able to recover. However, if the ischemia continues
nd perfusion is not restored, these factors lead to coag-
lative necrosis and tubular ﬁbrosis, which are irreversible
rocesses.9
A CT scan shows ischemic changes with greater accuracy
han US. In helical CT, changes that lead to renal papillary
ecrosis may be observed at the beginning of the corti-
omedullary phase, but these can be better described using
rography. In urography, changes are presented as poorly 1 6;3  8(3):267–270 269
margined areas of enhancement, which are reduced at the
point of the medullary pyramid.10
In this case, no regular outpatient follow-up was con-
ducted, which hampered the possibility of early intervention
with respect to the renal manifestations or any attempts to
prevent the vascular event in question. Measures to prevent
such renal lesions include angiotensin converting enzyme
inhibitors and hydroxyurea, which are believed to provide the
greatest beneﬁts in the control of sickle cell nephropathy. The
early identiﬁcation of risk factors for renal involvement may
allow the physician to provide appropriate treatment to the
patient.5,7,8
Studies indicate that lactate dehydrogenase (LDH) may be
used as an early marker for identifying the risk of kidney
failure in SCD patients. The serum LDH levels are used as a
measure of intravascular hemolysis, which is a major patho-
logical mechanism of cardiovascular complications as well as
pulmonary, gastrointestinal, and renal manifestations of SCD
patients.8,10 Exacerbated hemolysis is associated with early
mortality in patients with this disease.8
Regarding the clinical evolution of his disease, this patient
received hypertensive emergency treatment, including intra-
venous sodium nitroprusside and dialysis for blood volume
and metabolic control. He was then discharged and continued
to receive outpatient dialysis. The evolution of this disease will
undoubtedly increase the morbidity of SCD patients and it is
correlated with an increased mortality rate.
Conclusions
It is extremely important to recognize sickling mechanisms
and how they affect renal disorders. It is also necessary to
understand that renal changes occur over the years in SCD
patients, and when accompanied by clinical symptoms such
as hematuria, microalbuminuria, and proteinuria, it signals
the necessity of improved patient care. Prompt care will pre-
vent more  serious and permanent injuries such as renal
papillary necrosis and consequent renal insufﬁciency that
requires dialysis and can further impair the quality of life and
increase the mortality of SCD patients.
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